36 results match your criteria: "Germany [2] German Centre for Infection Research DZIF[Affiliation]"
Clin Vaccine Immunol
June 2015
Bernhard Nocht Institute for Tropical Medicine, WHO Collaborating Centre for Arbovirus and Hemorrhagic Fever Reference and Research, Hamburg, Germany German Centre for Infection Research (DZIF), Hamburg-Luebeck-Borstel partner site, Hamburg, Germany
To estimate the veterinary importance of Batai virus (BATV), we investigated the presence of BATV-specific antibodies and BATV RNA in 548 bovines from southwest Germany, and we demonstrated that 3 cattle serum samples contained BATV-neutralizing antibodies, resulting in a seroprevalence of 0.55%. Thus, our results confirm local transmission and indicate cattle as potential hosts of BATV in southwest Germany.
View Article and Find Full Text PDFJ Virol
June 2015
Institute of Virology, University of Bonn Medical Centre, Bonn, Germany German Centre for Infection Research (DZIF), partner sites Bonn-Cologne, Hamburg-Lübeck-Borstel, and Hannover-Braunschweig, Germany
Unlabelled: The hepatitis C virus (HCV; genus Hepacivirus) is a highly relevant human pathogen. Unique hepaciviruses (HV) were discovered recently in animal hosts. The direct ancestor of HCV has not been found, but the genetically most closely related animal HVs exist in horses.
View Article and Find Full Text PDFSex Transm Infect
September 2015
The GUIDE (genitourinary and infectious disease) Clinic, St. James Hospital, Dublin, Ireland.
Objectives: Syphilis recognition in HIV-positive patients has important implications. Initial data from this study, established in June 2012 to better understand the natural history of syphilis and treatment response, examine the characteristics of patients including sexual behaviour, rates of concurrent sexually transmitted infections (STI) and type of treatment given.
Methods: Patients were recruited from Ireland, Poland and Germany.
J Virol
April 2015
Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany German Centre for Infection Research (DZIF), Partner Site Hamburg, Hamburg, Germany
The development of treatments for Ebola virus disease (EVD) has been hampered by the lack of small-animal models that mimick human disease. Here we show that mice with transplanted human hematopoetic stem cells reproduce features typical of EVD. Infection with Ebola virus was associated with viremia, cell damage, liver steatosis, signs of hemorrhage, and high lethality.
View Article and Find Full Text PDFJ Virol
April 2015
Institute of Virology, University of Bonn Medical Centre, Bonn, Germany German Centre for Infection Research (DZIF), Bonn/Cologne, Germany
Unlabelled: Bats have been implicated as reservoirs of emerging viruses. Bat species forming large social groups and roosting in proximity to human communities are of particular interest. In this study, we sampled a colony of ca.
View Article and Find Full Text PDFJ Antimicrob Chemother
May 2015
Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Objectives: Aspergillus fumigatus is the most common agent of invasive aspergillosis (IA). In recent years, resistance to triazoles, the mainstay of IA therapy, has emerged in different countries worldwide. IA caused by azole-resistant A.
View Article and Find Full Text PDFAntimicrob Agents Chemother
February 2015
Institute of Medical Microbiology, Immunology and Parasitology-Pharmaceutical Microbiology Section, University of Bonn, Bonn, Germany German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany
Oritavancin is a semisynthetic derivative of the glycopeptide antibiotic chloroeremomycin with activity against Gram-positive pathogens, including vancomycin-resistant staphylococci and enterococci. Compared to vancomycin, oritavancin is characterized by the presence of two additional residues, a hydrophobic 4'-chlorobiphenyl methyl moiety and a 4-epi-vancosamine substituent, which is also present in chloroeremomycin. Here, we show that oritavancin and its des-N-methylleucyl variant (des-oritavancin) effectively inhibit lipid I- and lipid II-consuming peptidoglycan biosynthesis reactions in vitro.
View Article and Find Full Text PDFAntimicrob Agents Chemother
October 2014
Interfaculty Institute of Microbiology and Infection Medicine Tuebingen, Microbiology/Biotechnology, University of Tuebingen, Tuebingen, Germany German Centre for Infection Research (DZIF), Partner Site Tuebingen, Tuebingen, Germany
The emergence of antibiotic-resistant pathogenic bacteria within the last decades is one reason for the urgent need for new antibacterial agents. A strategy to discover new anti-infective compounds is the evaluation of the genetic capacity of secondary metabolite producers and the activation of cryptic gene clusters (genome mining). One genus known for its potential to synthesize medically important products is Amycolatopsis.
View Article and Find Full Text PDFJ Virol
October 2014
Institute of Virology, University of Bonn Medical Centre, Bonn, Germany
Unlabelled: The emerging Middle East respiratory syndrome coronavirus (MERS-CoV) causes lethal respiratory infections mainly on the Arabian Peninsula. The evolutionary origins of MERS-CoV are unknown. We determined the full genome sequence of a CoV directly from fecal material obtained from a South African Neoromicia capensis bat (NeoCoV).
View Article and Find Full Text PDFJ Virol
September 2014
Institute for Infectious Diseases and Zoonoses, LMU Munich, Germany German Centre for Infection Research (DZIF), Munich, Germany
Unlabelled: Immunization with modified vaccinia virus Ankara (MVA) can rapidly protect mice against lethal ectromelia virus (ECTV) infection, serving as an experimental model for severe systemic infections. Importantly, this early protective capacity of MVA vaccination completely depends on virus-specific cytotoxic CD8(+) T cell responses. We used MVA vaccination in the mousepox challenge model using ECTV infection to investigate the previously unknown factors required to elicit rapid protective T cell immunity in normal C57BL/6 mice and in mice lacking the interferon alpha/beta receptor (IFNAR(-/-)).
View Article and Find Full Text PDFJ Virol
September 2014
Institute for Infectious Diseases and Zoonoses, Ludwig-Maximilians-Universität München, Munich, Germany German Centre for Infection Research (DZIF), Munich, Germany
Unlabelled: Modified vaccinia virus Ankara (MVA) serves as a versatile platform in vaccine development. This highly attenuated orthopoxvirus, which cannot replicate in mammalian cells, triggers strong innate immune responses, including cell migration. Previously, we have shown that induction of chemokine (C-C motif) ligand 2 (CCL2) by MVA is necessary for the recruitment of monocytes and T cells, but not neutrophils, to the lung.
View Article and Find Full Text PDF